Abstract
Objectives
The impact of systemic lupus erythematosus (SLE) on preeclampsia is still obscure. This study was performed to systematically assess the association between preeclampsia and SLE.
Method
According to the PRISMA statement, designed literature research was performed in PubMed, Web of Science, and Cochrane Library from inception to June 30, 2018. The pooled risk ratio (RR) of preeclampsia in pregnant SLE patients compared with health controls was synthesized by fixed effect model or random effects model depending on heterogeneity.
Results
Ten studies involving 6,389 SLE patients were included. Pregnant women with SLE have significantly increased risk of preeclampsia (RR = 2.99, 95% CI = 2.31 to 3.88; Z = 8.31, P < 0.001) compared with health controls. Subgroup analysis showed that the risk of preeclampsia was significant (Q = 7.64, P = 0.006) higher in prospective studies (RR = 6.94, 95% CI = 3.59 to 13.42) compared to retrospective studies (RR = 2.60, 95% CI = 2.08 to 3.25).
Conclusions
The present study demonstrated that pregnant SLE patients have a high risk of preeclampsia, suggesting a pivotal role of SLE in the pathogenesis of preeclampsia. For rheumatologists and SLE patients, it is important to maintain inactive disease activity and prevent complications as LN, and the control of traditional risk factors of preeclampsia is also pivotal. Further study focus on the prevention of preeclampsia in SLE is also urgent.
Similar content being viewed by others
References
Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365:2110–2121. https://doi.org/10.1056/NEJMra1100359
Meyer O (2004) Making pregnancy safer for patients with lupus. Joint Bone Spine; 71:178-182.https://doi.org/10.1016/s1297-319x(03)00155-6
Silva CA, Leal MM, Leone C, Simone VP, Takiuti AD, Saito MI, Kiss MH (2002) Gonadal function in adolescents and young women with juvenile systemic lupus erythematosus. Lupus 11:419–425. https://doi.org/10.1191/0961203302lu219oa
Simard JF, Arkema EV, Nguyen C, Svenungsson E, Wikstrom AK, Palmsten K et al (2017) Early-onset preeclampsia in lupus pregnancy. Paediatr Perinat Epidemiol 31:29–36. https://doi.org/10.1111/ppe.12332
Baer AN, Witter FR, Petri M (2011) Lupus and pregnancy. Obstet Gynecol Surv 66:639–653. https://doi.org/10.1097/OGX.0b013e318239e1ee
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725. https://doi.org/10.1002/1529-0131(199709)40:9<1725::AID-ART29>3.0.CO;2-Y
Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, Vogel JP et al (2014) Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. Bjog 121(Suppl 1):14–24. https://doi.org/10.1111/1471-0528.12629
Burton GJ, Redman CW, Roberts JM, Moffett A (2019) Pre-eclampsia: pathophysiology and clinical implications. Bmj 366:l2381. https://doi.org/10.1136/bmj.l2381
Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ (2016) Pre-eclampsia. Lancet 387:999–1011. https://doi.org/10.1016/s0140-6736(15)00070-7
Chakravarty EF, Colon I, Langen ES, Nix DA, El-Sayed YY, Genovese MC et al (2005) Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 192:1897–1904. https://doi.org/10.1016/j.ajog.2005.02.063
Chakravarty EF, Nelson L, Krishnan E (2006) Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 54:899–907. https://doi.org/10.1002/art.21663
Jakobsen IM, Helmig RB, Stengaard-Pedersen K (2015) Maternal and foetal outcomes in pregnant systemic lupus erythematosus patients: an incident cohort from a stable referral population followed during 1990-2010. Scand J Rheumatol 44:377–384. https://doi.org/10.3109/03009742.2015.1013982
Clowse ME, Jamison M, Myers E, James AH (2008) A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 199:127.e1-6. https://doi.org/10.1016/j.ajog.2008.03.012
Moher D, Liberati A, Tetzlaff J, Altman DG (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:336–341. https://doi.org/10.1016/j.ijsu.2010.02.007
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama 283:2008–2012
Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605. https://doi.org/10.1007/s10654-010-9491-z
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558. https://doi.org/10.1002/sim.1186
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Bmj 327:557–560. https://doi.org/10.1136/bmj.327.7414.557
Borenstein M, Hedges LV, Higgins JP, Rothstein HR (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 1:97–111. https://doi.org/10.1002/jrsm.12
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Bmj 315:629–634
Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101
Ling N, Lawson E, von Scheven E (2018) Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate. Pediatr Rheumatol Online J 16:26. https://doi.org/10.1186/s12969-018-0242-0
Wu J, Ma J, Bao C, Di W, Zhang WH (2018) Pregnancy outcomes among Chinese women with and without systemic lupus erythematosus: a retrospective cohort study. BMJ Open 8:e020909. https://doi.org/10.1136/bmjopen-2017-020909
Abdwani R, Al Shaqsi L, Al-Zakwani I (2018) Neonatal and obstetrical outcomes of pregnancies in systemic lupus erythematosus. Oman Med J 33:15–21. https://doi.org/10.5001/omj.2018.04
Phansenee S, Sekararithi R, Jatavan P, Tongsong T (2018) Pregnancy outcomes among women with systemic lupus erythematosus: a retrospective cohort study from Thailand. Lupus 27:158–164. https://doi.org/10.1177/0961203317721353
Hamed HO, Ahmed SR, Alzolibani A, Kamal MM, Mostafa MS, Gamal RM, Atallah DA, Abd-el-Aall DE (2013) Does cutaneous lupus erythematosus have more favorable pregnancy outcomes than systemic disease? A two-center study. Acta Obstet Gynecol Scand 92:934–942. https://doi.org/10.1111/aogs.12158
Barnado A, Wheless L, Meyer AK, Gilkeson GS, Kamen DL (2014) Pregnancy outcomes among African-American patients with systemic lupus erythematosus compared with controls. Lupus Sci Med 1:e000020. https://doi.org/10.1136/lupus-2014-000020
Wallenius M, Salvesen KA, Daltveit AK, Skomsvoll JF (2014) Systemic lupus erythematosus and outcomes in first and subsequent births based on data from a national birth registry. Arthritis Care Res 66:1718–1724. https://doi.org/10.1002/acr.22373
Barnabe C, Faris PD, Quan H (2011) Canadian pregnancy outcomes in rheumatoid arthritis and systemic lupus erythematosus. Int J Rheumatol 2011:345727. https://doi.org/10.1155/2011/345727
Stirrat GM, Redman CW, Levinsky RJ (1978) Circulating immune complexes in pre-eclampsia. Br Med J 1:1450–1451
Yamamoto T, Yoshimura S, Geshi Y, Sasamori Y, Mori H, Kobayashi T (1994) Anti-ssDNA and dsDNA antibodies in preeclampsia. Asia Oceania J Obstet Gynaecol 20:93–99
Zhao C, Zhao J, Huang Y, Wang Z, Wang H, Zhang H, Xu H, Yang N (2013) New-onset systemic lupus erythematosus during pregnancy. Clin Rheumatol 32:815–822. https://doi.org/10.1007/s10067-013-2180-z
Chen D, Lao M, Cai X, Li H, Zhan Y, Wang X, Zhan Z (2019) Hypertensive disorders of pregnancy associated with adverse pregnant outcomes in patients with systemic lupus erythematosus: a multicenter retrospective study. Clin Rheumatol:1–9. https://doi.org/10.1007/s10067-019-04696-x
Kattah AG, Garovic VD (2015) Pregnancy and Lupus Nephritis. Semin Nephrol 35:487–499. https://doi.org/10.1016/j.semnephrol.2015.08.010
Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD (2010) A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 5:2060–2068. https://doi.org/10.2215/cjn.00240110
Wu J, Ma J, Zhang WH, Di W (2018) Management and outcomes of pregnancy with or without lupus nephritis: a systematic review and meta-analysis. Ther Clin Risk Manag 14:885–901. https://doi.org/10.2147/tcrm.s160760
Ugolini-Lopes MR, Torrezan GT, Gandara APR, Olivieri EHR, Nascimento IS, Okazaki E et al (2019) Enhanced type I interferon gene signature in primary antiphospholipid syndrome: Association with earlier disease onset and preeclampsia. Autoimmun Rev. https://doi.org/10.1016/j.autrev.2018.11.004
Levine JS, Branch DW, Rauch J (2002) The antiphospholipid syndrome. N Engl J Med 346:752–763. https://doi.org/10.1056/NEJMra002974
Andrade D, Kim M, Blanco LP, Karumanchi SA, Koo GC, Redecha P, Kirou K, Alvarez AM, Mulla MJ, Crow MK, Abrahams VM, Kaplan MJ, Salmon JE (2015) Interferon-alpha and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia. Arthritis Rheum 67:977–987. https://doi.org/10.1002/art.39029
Acknowledgments
This study was supported by Grants National Natural Science Foundation of China (No. 81573217). We also appreciate the efforts of all the researchers whose articles were included in this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 639 kb)
Rights and permissions
About this article
Cite this article
Dong, Y., Yuan, F., Dai, Z. et al. Preeclampsia in systemic lupus erythematosus pregnancy: a systematic review and meta-analysis. Clin Rheumatol 39, 319–325 (2020). https://doi.org/10.1007/s10067-019-04823-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-019-04823-8